INKT
INKT
NASDAQ · Biotechnology

Mink Therapeutics Inc

$9.34
-0.19 (-1.99%)
As of Nov 13, 10:10 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +113.8% upside
Low Target $17.96
Average Target $19.97
High Target $26.10
Current Price $9.34
Current
$9.34
Target
$19.97
$17.96 $19.97 avg $26.10
Scenario Analysis
Bear Case
$17.96
92.3%
Low target
Base Case
$19.97
+113.8%
Avg target
Bull Case
$26.10
+179.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$16.93
-44.8% from high
52-Week Low
$8.48
+10.1% from low
Target vs 52W High
$19.97
+18.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%